# Feasibility and Safety of Hybrid Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Colon Cancer

> **NCT04048421** · NA · UNKNOWN · sponsor: **Renmin Hospital of Wuhan University** · enrollment: 55 (estimated)

## Conditions studied

- Colon Cancer
- Natural Orifice Transluminal Endoscopic Surgery

## Interventions

- **PROCEDURE:** hvNOTES radical colectomy

## Key facts

- **NCT ID:** NCT04048421
- **Lead sponsor:** Renmin Hospital of Wuhan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-20
- **Primary completion:** 2024-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2023-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04048421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04048421, "Feasibility and Safety of Hybrid Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Colon Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04048421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*